EGFR and non-small cell lung carcinoma: Previous studies have shown that the canonical Wnt pathway contributes to the maintenance of NSCLC cells during EGFR inhibition and that the efficacy of EGFR inhibitors can be significantly improved by inhibiting various components of the canonical Wnt pathway.